Core Viewpoint - The comparison between Oshkosh (OSK) and Ingersoll Rand (IR) indicates that OSK presents a better value opportunity for investors at this time [1]. Valuation Metrics - OSK has a forward P/E ratio of 12.53, significantly lower than IR's forward P/E of 23.35 [5]. - The PEG ratio for OSK is 1.72, while IR's PEG ratio is considerably higher at 4.31, suggesting OSK is more reasonably priced relative to its expected earnings growth [5]. - OSK's P/B ratio stands at 1.97, compared to IR's P/B ratio of 3.08, indicating that OSK is undervalued in terms of market value versus book value [6]. - These metrics contribute to OSK receiving a Value grade of B, while IR has a Value grade of D [6]. Earnings Outlook - OSK is experiencing an improving earnings outlook, which enhances its attractiveness in the Zacks Rank model [7]. - The positive earnings estimate revisions for OSK suggest a more favorable earnings outlook compared to IR, which is rated as a Hold [3][7].

Group 1 - The company differentiates itself from broader industrials through a strong M&A engine, identifying 4 to 5 points of M&A growth annually and effectively integrating them to enhance margins [1] - The company promotes a unique ownership mindset culture among its 25,000 employees, teaching them to think like owners and focus on cash conversion cycles [2] - The combination of the ownership mindset and the Ingersoll Rand Execution Excellence (IRX) operational framework contributes to the company's unique approach to M&A, generating high free cash flow margins of nearly 20% [3]

Ingersoll Rand FY Conference Summary Company Overview - **Company**: Ingersoll Rand (NYSE: IR) - **Date of Conference**: September 11, 2025 - **Key Speakers**: CEO Vicente Reynal, CFO Vikram Kini Key Points M&A Strategy - Ingersoll Rand differentiates itself through a strong M&A engine, identifying 4-5 growth opportunities annually and integrating them effectively to enhance margins [3][4] - The company has completed 75 acquisitions over the past five years, with 90% being family-owned or founder-based, achieving an average pre-synergy EBITDA multiple of 9.5 times [4][12] - The integration process is decentralized, occurring within nine P&L leaders, allowing for rapid synergy realization [5][6] Financial Performance - The company generates a free cash flow margin of 15-20%, which is reinvested into bolt-on acquisitions [3][4] - Ingersoll Rand aims for a mid-teens return on invested capital (ROIC) by year three post-acquisition [4] Market Position and Growth - The company operates in a $75 billion addressable market with $7.5 billion in revenue, indicating significant growth potential in a fragmented market [11] - Ingersoll Rand focuses on acquiring companies with gross margins in the mid-30s or higher, emphasizing pricing power and unique technology [9][10] Energy Efficiency and ROI - Compressors account for 30-40% of energy consumption in manufacturing facilities, with 80% of ownership costs attributed to electricity over a 10-year lifespan [13][14] - The average payback period for energy-efficient compressors is now less than two years, with many customers realizing the need for energy savings [15][16] Service Model Transition - Ingersoll Rand is transitioning from a traditional parts business to a care model, targeting $1 billion in recurring revenue by 2027, with $300 million achieved in 2024 [17][18] - The care model includes performance guarantees and multi-year contracts, enhancing gross margins significantly [19][24] Market Dynamics - The company reports stable market conditions, with positive organic growth in China and strong performance in Europe, while North America remains cautious due to tariff uncertainties [26][29][30] - Ingersoll Rand is focusing on underpenetrated markets in Latin America and Southeast Asia, leveraging local partnerships to drive growth [33][34] Tariff Impact - The recent tariff policies have created uncertainty, but Ingersoll Rand believes its U.S. manufacturing capabilities provide a competitive advantage [51][52] - The company is managing cost increases due to tariffs without passing on margin increases to customers, maintaining a neutral impact on EBITDA [56] Pricing Strategy - Ingersoll Rand employs a total cost of ownership approach in pricing, ensuring that price increases are justified by ROI for customers [58][59] - There is some pricing fatigue in the market due to frequent price adjustments, but the company remains agile in navigating these dynamics [58][59] Margin Outlook - The company anticipates margin expansion in the second half of the year, driven by seasonal volume increases and prudent cost management [62][64] - Integration of recent acquisitions, such as ILC Dover, is expected to contribute positively to margins [64][65] Additional Insights - The care model is seen as the biggest organic growth initiative for Ingersoll Rand, with potential for expansion across various product lines [21][22] - The company is exploring innovative solutions to enhance recurring revenue and improve gross margins further [25][26] This summary encapsulates the key insights and strategic directions discussed during the Ingersoll Rand FY Conference, highlighting the company's focus on M&A, energy efficiency, service model transformation, and market dynamics.

Company Overview - Ingersoll Rand Inc. (IR) is valued at a market cap of $31.9 billion and provides mission-critical air, fluid, energy, and medical technologies services and solutions [1] - The company is based in Davidson, North Carolina, and serves various industries including manufacturing, energy, life sciences, and food & beverage [1][2] Market Position - Ingersoll Rand is classified as a "large-cap stock" due to its market cap exceeding $10 billion, highlighting its size and influence in the specialty industrial machinery industry [2] - The company has a broad portfolio of industrial solutions and a strong global service network, ensuring consistent aftermarket revenue [2] Stock Performance - Ingersoll Rand's stock has decreased 24.3% from its 52-week high of $106.03, reached on November 25, 2024 [3] - Over the past three months, shares have declined 5.3%, underperforming the Nasdaq Composite's 11% return [3] - The stock has fallen 8.9% over the past 52 weeks, significantly lagging behind the NASX's 28.6% increase during the same period [4] - Year-to-date, shares are down 11.3%, compared to NASX's 13.3% rise [4] - The stock has been trading below its 200-day moving average since mid-December 2024 and below its 50-day moving average since early August [4] Financial Performance - Ingersoll Rand reported Q2 earnings on July 31, with revenue growing 4.6% year-over-year to $1.9 billion, exceeding consensus estimates by 2.7% [5] - The adjusted EPS was $0.80, meeting analyst forecasts [5] - The company raised its fiscal 2025 guidance, projecting revenue growth of 4% to 6% and adjusted EPS between $3.34 and $3.46 [5] - Despite the positive earnings report, shares fell 11.4% in the following trading session, attributed to a 3.6% year-over-year decline in adjusted EPS and a 40-basis point drop in adjusted EBITDA margin [5] - Free cash flow decreased by 25.7% from the prior-year quarter, impacting investor sentiment [5]

Core Insights - Oshkosh (OSK) currently presents a stronger investment opportunity compared to Ingersoll Rand (IR) based on Zacks Rank and valuation metrics [3][7] Valuation Metrics - OSK has a forward P/E ratio of 13.09, significantly lower than IR's forward P/E of 23.80 [5] - The PEG ratio for OSK is 1.80, while IR's PEG ratio is considerably higher at 4.39, indicating OSK's better valuation relative to its expected earnings growth [5] - OSK's P/B ratio stands at 2.06, compared to IR's P/B ratio of 3.14, further supporting OSK's valuation advantage [6] Analyst Outlook - OSK holds a Zacks Rank of 1 (Strong Buy), indicating a more favorable earnings estimate revision activity compared to IR, which has a Zacks Rank of 3 (Hold) [3][7] - The Value grade for OSK is B, while IR has a Value grade of D, highlighting OSK's superior valuation metrics [6]

Core Viewpoint - The comparison between Luxfer (LXFR) and Ingersoll Rand (IR) indicates that LXFR currently offers better value for investors based on various financial metrics and rankings [1][3]. Valuation Metrics - Luxfer has a forward P/E ratio of 11.05, significantly lower than Ingersoll Rand's forward P/E of 23.59 [5]. - The PEG ratio for Luxfer is 1.38, while Ingersoll Rand's PEG ratio is 3.21, suggesting that Luxfer is more reasonably priced relative to its expected earnings growth [5]. - Luxfer's P/B ratio stands at 1.28, compared to Ingersoll Rand's P/B of 3.08, indicating that Luxfer is trading at a lower valuation relative to its book value [6]. Zacks Rank and Style Scores - Luxfer holds a Zacks Rank of 2 (Buy), while Ingersoll Rand has a Zacks Rank of 3 (Hold), suggesting a stronger earnings outlook for Luxfer [3]. - The Style Score Value grade for Luxfer is A, whereas Ingersoll Rand has a Value grade of D, further emphasizing Luxfer's superior valuation metrics [6]. Estimate Revisions - Luxfer has experienced stronger estimate revision activity compared to Ingersoll Rand, making it a more attractive option for value investors [7].

Core Viewpoint - Ingersoll Rand Inc. has acquired Dave Barry Plastics to enhance its life sciences portfolio, reflecting the company's commitment to innovative and high-performance solutions in the industry [1][3]. Company Overview - Ingersoll Rand Inc. is a global provider of mission-critical flow creation and life science and industrial solutions, supported by over 80 respected brands [4]. - The company aims to improve performance and durability in complex and harsh conditions, focusing on customer satisfaction and long-term relationships [4]. Acquisition Details - Dave Barry Plastics, based in Ireland, specializes in designing and manufacturing plastic product solutions for the life science and healthcare technology industries, particularly for clean rooms [2]. - The acquisition will integrate Dave Barry Plastics into Ingersoll Rand's Life Sciences platform within the Precision and Science Technologies (P&ST) segment [2]. Strategic Implications - The acquisition supports Ingersoll Rand's growth strategy by providing opportunities for innovation, market expansion, and long-term value creation within the life sciences sector [7]. - The investment was made at an attractive purchase multiple of approximately 9 times the 2024 Adjusted EBITDA, indicating a strategic financial decision [7].

Core Insights - Ingersoll Rand reported record GAAP revenue of $1,887.9 million for Q2 2025, exceeding analyst expectations by $40.6 million, while adjusted EPS (Non-GAAP) was $0.80, matching estimates [1][2] - Despite revenue growth, the company faced margin pressures, a significant drop in free cash flow, and a net loss due to non-cash impairments [1][6] Financial Performance - GAAP revenue increased by 4.6% year-over-year from $1,805.3 million in Q2 2024 to $1,887.9 million in Q2 2025 [2] - Adjusted EBITDA was $509.4 million, up 3.0% from $494.6 million in Q2 2024 [2] - Free cash flow decreased by 25.7% year-over-year, from $283.1 million in Q2 2024 to $210.4 million in Q2 2025 [2] - Adjusted EBITDA margin fell to 27.0%, down 0.4 percentage points from the previous year [2] Business Overview - Ingersoll Rand offers a wide range of flow creation products, including compressors, pumps, and vacuum equipment, across various sectors such as life sciences and clean energy [3] - The company operates under more than 80 brands, focusing on both new equipment and recurring aftermarket services [3] Strategic Focus - The company is concentrating on expanding its product portfolio, enhancing aftermarket services for recurring revenue, and pursuing strategic acquisitions [4] - Aftermarket revenues accounted for 36.4% of total revenue in 2024, providing stability [4][9] Quarterly Highlights - Order volume reached a new high of $1,940 million, up 8% year-over-year, driven by acquisitions and pricing actions [5] - Organic revenue declined by 3.4%, indicating weaker demand in legacy businesses [5] Profitability Metrics - The Industrial Technologies & Services unit reported GAAP revenue of $1,492 million, up 2% overall but down 3.8% organically [7] - The Precision & Science Technologies segment saw a 17% revenue increase, but underlying organic revenue fell by 1.6% [7] Pricing Actions and Cost Management - Pricing actions were implemented in response to new tariffs, matching cost increases without improving margins [8][9] - Cost-saving efforts are expected to take longer to materialize [9] Notable Events - The quarter included significant non-cash impairments, including $229.7 million in goodwill and $36.1 million in other intangible assets [10] Capital Allocation and Future Outlook - Ingersoll Rand allocated $47 million towards acquisitions and completed two deals, while also engaging in share buybacks totaling $500 million [11] - Management raised its revenue and adjusted earnings outlook for FY2025, projecting a revenue increase of 4% to 6% [12] - The organic revenue guidance remains cautious, reflecting potential demand growth challenges [12] Investor Considerations - Key areas for investor focus include managing margin pressure, free cash flow performance, and the impact of future non-cash impairments [13]

Core Insights - Ingersoll Rand Inc. reported second-quarter 2025 adjusted earnings of $0.80 per share, matching the Zacks Consensus Estimate, but reflecting a 3.6% year-over-year decrease [1] - Total revenues reached $1.89 billion, exceeding the consensus estimate of $1.84 billion, with a year-over-year increase of 4.6% driven by acquisitions and foreign currency movements, while organic revenues decreased by 3.9% [1][11] Revenue and Orders - Orders totaled $1.94 billion, marking a 7.8% year-over-year increase, although organic orders saw a slight decline of 0.1% [2] - The Industrial Technologies & Services segment generated revenues of $1.49 billion, accounting for 79% of total revenues, with a year-over-year sales increase of 1.7% [3] - The Precision & Science Technologies segment reported revenues of $396.3 million, representing 21% of total revenues, with a significant year-over-year increase of 17% [5] Segment Performance - Adjusted EBITDA for the Industrial Technologies & Services segment decreased by 2.1% year over year to $427.2 million, while the Precision & Science Technologies segment's adjusted EBITDA increased by 14% to $116.8 million [4][6] - The overall adjusted EBITDA for the company increased by 3% year over year to $509.4 million, with a margin decrease to 27% from 27.4% in the previous year [7] Financial Position - As of the end of the second quarter, Ingersoll Rand had cash and cash equivalents of $1.31 billion, down from $1.54 billion at the end of December 2024, while long-term debt increased slightly to $4.78 billion [8] - The company generated net cash of $502.1 million from operating activities, reflecting a 7.6% year-over-year increase, and free cash flow rose by 13.3% to $433.1 million [9] 2025 Outlook - Ingersoll Rand raised its 2025 EPS guidance to a range of $3.34-$3.46, indicating a 2-5% growth from the previous year [11][13] - The company expects total revenues to increase by 4-6% year over year, with organic revenues anticipated to decrease by 2% to remain flat [12]

Financial Data and Key Metrics Changes - The company raised its full year guidance on revenue, adjusted EBITDA, and adjusted EPS due to a strong start in the first half of the year [6][28] - Adjusted EBITDA for the second quarter was $509 million, with an adjusted EBITDA margin of 27%, reflecting a year-over-year decline primarily due to organic volume declines and the impact of recently acquired businesses [15][21] - Adjusted earnings per share for the quarter was $0.80, which is up 18% on a two-year stack [17] Business Line Data and Key Metrics Changes - In the ITS segment, second quarter orders were up 7% year over year, with organic order growth in the low single digits [22] - The PSC segment saw orders increase by 13% year over year, with revenue up 17% largely driven by M&A [25][26] - Aftermarket revenue accounted for 37% of total revenue, up 100 basis points year over year [15] Market Data and Key Metrics Changes - Orders in the Americas were up high teens, EMEA up high single digits, and Asia Pacific up low double digits [23] - Organic order growth in China was noted, reflecting the effectiveness of demand generation initiatives [23] Company Strategy and Development Direction - The company continues to focus on sustainability and innovation, having been ranked number one in North America and globally in its industry on the Dow Jones sustainability indices [8] - The capital allocation strategy prioritizes M&A, with 11 transactions closed this year, totaling over $200 million in annualized revenue [10][20] - The company aims to leverage its strong balance sheet to strategically deploy capital and drive value for shareholders [31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the full year outlook, supported by a book-to-bill ratio of 1.06 and a total backlog increase of 16% since 2024 [6] - The macro environment remains dynamic, but business conditions are stable, with positive signs in internal indicators [30] - Management remains cautious about the volume side, continuing to adopt a precautionary approach in guidance [94] Other Important Information - The company recorded non-cash goodwill and asset impairments related to the High Pressure Solutions business and ILC Dover, but these adjustments did not affect adjusted earnings [17][19] - Total company liquidity is currently $3.9 billion, underscoring the strength of the balance sheet [20] Q&A Session Summary Question: Demand cadence in the back half of the year - Management noted a stable continuation of demand through the second quarter, with a good backlog setting up for the second half [38] Question: Margins in the back half of the year - Management indicated that margin improvement is expected due to seasonality and productivity initiatives [40][42] Question: Phasing of sales and EBITDA in the second half - Management confirmed that the phasing of revenue and EBITDA is consistent with prior guidance, expecting a better second half compared to the first [46][47] Question: Legacy Gardner Denver Medical business performance - Management reported good momentum in the fluid handling side of the business, particularly in cancer research [79] Question: Long-term growth algorithm for compressors - Management reassured that the long-term growth outlook remains unchanged, with expectations for stable growth despite fluctuations in large projects [106]